Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 August 2005, Vol. 106, No. 3, pp. 769.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleming, W. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fleming, W. H.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow


InsideBlood

HEMATOPOIESIS

Comment on Kim et al, page 903

Endothelial cell–specific markers: going... going... gone

William H. Fleming

OREGON HEALTH & SCIENCE UNIVERSITY

VE-cadherin, an adhesion molecule thought to be exclusively expressed on endothelial cells, has now been identified on fetal hematopoietic stem cells.

Accumulating evidence supports the existence of a common hematopoietic/endothelial stem cell during early embryonic development,1 and recent studies suggest that cells with hemangioblast activity persist into adult life in both mice2,3 and humans.4 Gene targeting of embryonic stem cells reveals that a number of regulatory molecules including Runx-1, SCL, and fetal liver kinase-1 (FLK-1) are important for the specification of both blood and blood vessels in the early embryo. Many of the genes originally thought to be exclusively expressed in vascular endothelium have turned up in hematopoietic stem/progenitor cells (HSCs), while transcription factors and membrane receptors first associated with HSCs have been identified in the endothelial cell compartment. Consequently, these overlapping patterns of gene expression have led to an ever-diminishing list of endothelial-specific genes.Go



View larger version (68K):
[in this window]
[in a new window]
 
E13.5 fetal liver HSCs express the endothelial marker CD144 (VE-cadherin), but CD144 expression by HSCs declines over time and is no longer detected on adult bone marrow HSCs. See the complete figure in the article beginning on page 903.

 
Vascular endothelial (VE)–cadherin (CD144) is an adhesion molecule that mediates cell-cell contact between endothelial cells.5 Reporter gene analysis shows that VE-cadherin is expressed in virtually all vascular structures including the blood islands of the yolk sac, the developing aorta, and capillaries of the brain. In the adult, continued expression in the endothelium is found throughout the vascular system. Targeted disruption of VE-cadherin impairs the remodeling, maturation, and survival of endothelial cells, ultimately leading to embryonic lethality. Constitutive expression in vascular tissue coupled with important functional activity has led to the widely accepted concept that VE-cadherin is endothelial cell specific. Careful investigation of the fetal HSC compartment once again challenges the notion of endothelial-specific genes.

In this issue of Blood, Kim and colleagues, using a combination of microarray analysis and quantitative polymerase chain reaction (qPCR), report that the levels of VE-cadherin expression are 13- to 50-fold greater in fetal liver HSCs compared with adult bone marrow (BM) HSCs. By sorting embryonic day (E) 13.5 fetal liver based on CD144 expression, they convincingly demonstrate that essentially all of the transplantable HSC activity segregates to the CD144+ cell fraction. However, on E16.5, both the CD144+ and CD144 fractions contain functional HSCs as determined using both primary and secondary transplantation assays. By contrast, all HSC activity in adult BM was found in the CD144 cell population. In addition to identifying a novel marker for enriching E13.5 FL HSCs, this study provides additional evidence of the phenotypic overlap between early HSCs and vascular endothelium, further underscoring the close relationship between hematopoiesis and blood vessels.6 The results of this study also illustrate the importance of using a panel of markers in order to reliably distinguish fetal HSCs and endothelial cells. {blacksquare}

References

  1. Lacaud G, Robertson S, Palis J, Kennedy M, Keller G. Regulation of hemangioblast development. Ann N Y Acad Sci. 2001;938: 96-107.[Medline] [Order article via Infotrieve]

  2. Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 2002;8: 607-612.[CrossRef][Medline] [Order article via Infotrieve]

  3. Bailey AS, Jiang S, Afentoulis M, et al. Transplanted adult hematopoietic stem cells differentiate into functional endothelial cells. Blood. 2004;103: 13-19.[Abstract/Free Full Text]

  4. Pelosi E, Valtieri M, Coppola S, et al. Identification of the hemangioblast in postnatal life. Blood. 2002;100: 3203-3208.[Abstract/Free Full Text]

  5. Breier G, Breviario F, Caveda L, et al. Molecular cloning and expression of murine vascular endothelial-cadherin in early stage development of cardiovascular system. Blood. 1996;87: 630-641.[Abstract/Free Full Text]

  6. Bailey AS, Fleming WH. Converging roads: evidence for an adult hemangioblast. Exp Hematol. 2003;31: 987-993.[Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

CD144 (VE-cadherin) is transiently expressed by fetal liver hematopoietic stem cells
Injune Kim, Ömer H. Yilmaz, and Sean J. Morrison
Blood 2005 106: 903-905. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleming, W. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fleming, W. H.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020